Drug class
Non-steroidal anti-inflammatory drug (NSAID); nicotinic-acid derivative
Mechanism of action
The molecular mechanism is not fully characterised. As an NSAID, its pharmacology is presumed to include cyclo-oxygenase-mediated reduction of prostaglandin synthesis, contributing to analgesic and anti-inflammatory effects; this should be regarded as a class-based mechanism rather than a fully established compound-specific target profile.
General use cases
- Management of pain and inflammation associated with chronic arthritic conditions and selected soft-tissue disorders in jurisdictions where clonixin is authorised
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
